APA (7th ed.) Citation

M, W., EB, W., AP, D., SL, P., M, C., YM, E., . . . GP, C. (2022). Oncolytic virus treatment differentially affects the CD56dim and CD56bright NK cell subsets in vivo and regulates a spectrum of human NK cell activity. Immunology, 166(1), 104. https://doi.org/10.1111/imm.13453

Chicago Style (17th ed.) Citation

M, Wantoch, et al. "Oncolytic Virus Treatment Differentially Affects the CD56dim and CD56bright NK Cell Subsets in Vivo and Regulates a Spectrum of Human NK Cell Activity." Immunology 166, no. 1 (2022): 104. https://doi.org/10.1111/imm.13453.

MLA (9th ed.) Citation

M, Wantoch, et al. "Oncolytic Virus Treatment Differentially Affects the CD56dim and CD56bright NK Cell Subsets in Vivo and Regulates a Spectrum of Human NK Cell Activity." Immunology, vol. 166, no. 1, 2022, p. 104, https://doi.org/10.1111/imm.13453.